BMC rheumatology

Keyphrases

Publications

volume 8, number 1, 2024

Atiyeh Mellati, Samaneh Soltani, Tohid Kazemi, Nooshin Ahmadzadeh, Maryam Akhtari, Elham Madreseh, Ahmadreza Jamshidi, Elham Farhadi, Mahdi Mahmoudi
Determination of IL-23 receptor expression and gene polymorphism (rs1884444) in Iranian patients with ankylosing spondylitis. BMC rheumatology 8 (1) (2024)
Julie Katrine Karstensen, Ann Bremander, Jeanette Reffstrup Christensen, Jette Primdahl
Participation in cardiovascular screening consultations, the who, when and why - A cohort study on patients with rheumatoid arthritis. BMC rheumatology 8 (1) (2024)
Jorge Enrique Sinclair, Shahin Isha, Lorenzo Olivero, Lekhya Raavi, Sai Abhishek Narra, Smit Paghdar, Sadhana Jonna, Parthkumar Satashia, Rachel Hannon, Jessica Blasavage, Layton White, Titilope Olanipekun, Pankaj Bansal, Sean Kiley, Juan Carlos Leoni, Jose Nativí, Melissa Lyle, Mathew Thomas, Basar Sareyyupoglu, Si Pham, Michael Smith, Pablo Moreno Franco, Parag C Patel, Devang Sanghavi
Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched study. BMC rheumatology 8 (1) (2024)
Danfeng Xu, Bing Wu
Association between systemic lupus erythematosus and osteoporosis: a mendelian randomization analysis. BMC rheumatology 8 (1) (2024)
Atsuko Tsujii, Kentaro Isoda, Maiko Yoshimura, Akihiko Nakabayashi, Dong-Seop Kim, Tatsuya Tamada, Kurumi Yamamoto, Shiro Ohshima
Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study. BMC rheumatology 8 (1) (2024)
Jingying Lan, Chaoqiong Deng, Heqing Huang, Peishi Rao, Yangchun Chen, Yingying Shi, Jie Chen, Guixiu Shi, Yuan Liu, Shiju Chen
Seronegative primary Sjögren's syndrome, a distinct subtype of primary Sjögren's syndrome in Chinese patients. BMC rheumatology 8 (1) (2024)
Esteban Rubio Romero, Cesar Diaz-Torné, María José Moreno-Martínez, Julen De-Luz
Methotrexate treatment strategies for rheumatoid arthritis: a scoping review on doses and administration routes. BMC rheumatology 8 (1) (2024)
Esteban Rubio Romero, Cesar Diaz-Torné, María José Moreno-Martínez, Julen De-Luz
Methotrexate treatment strategies for rheumatoid arthritis: a scoping review on doses and administration routes. BMC rheumatology 8 (1) (2024)
Zahra A Fazal, Ana Michelle Avina-Galindo, Shelby Marozoff, Jessie Kwan, Na Lu, J Antonio Avina-Zubieta
Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies. BMC rheumatology 8 (1) (2024)
Atsuko Tsujii, Kentaro Isoda, Maiko Yoshimura, Akihiko Nakabayashi, Dong-Seop Kim, Tatsuya Tamada, Kurumi Yamamoto, Shiro Ohshima
Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study. BMC rheumatology 8 (1) (2024)
Michael Schultze, Elena Garal-Pantaler, Marc Pignot, Roger A Levy, Heike Carnarius, Matthias Schneider, Kerry Gairy
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany. BMC rheumatology 8 (1) (2024)
Lei Zhu, Larry W Moreland, Dana P Ascherman
Cross-sectional association between social and demographic factors and disease activity in rheumatoid arthritis. BMC rheumatology 8 (1) (2024)
Michael Schultze, Elena Garal-Pantaler, Marc Pignot, Roger A Levy, Heike Carnarius, Matthias Schneider, Kerry Gairy
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany. BMC rheumatology 8 (1) (2024)
Jingying Lan, Chaoqiong Deng, Heqing Huang, Peishi Rao, Yangchun Chen, Yingying Shi, Jie Chen, Guixiu Shi, Yuan Liu, Shiju Chen
Seronegative primary Sjögren's syndrome, a distinct subtype of primary Sjögren's syndrome in Chinese patients. BMC rheumatology 8 (1) (2024)
Cécile-Audrey Durel, Eric Simon Thervet, Dominique Chauveau, Aurélie Schmidt, Benjamin Terrier, Pierre M Bataille
Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use. BMC rheumatology 8 (1) (2024)
Nasimah Maricar, Gillian Yeowell, Trixy David, Behram Khan, Anne Barton, Kimme L Hyrich, Sandra E Hartley
Barriers and enablers to engagement in exercise and physical activity in non-English speaking South Asian people with chronic musculoskeletal disease. BMC rheumatology 8 (1) (2024)
Nasimah Maricar, Gillian Yeowell, Trixy David, Behram Khan, Anne Barton, Kimme L Hyrich, Sandra E Hartley
Barriers and enablers to engagement in exercise and physical activity in non-English speaking South Asian people with chronic musculoskeletal disease. BMC rheumatology 8 (1) (2024)
Jorge Enrique Sinclair, Shahin Isha, Lorenzo Olivero, Lekhya Raavi, Sai Abhishek Narra, Smit Paghdar, Sadhana Jonna, Parthkumar Satashia, Rachel Hannon, Jessica Blasavage, Layton White, Titilope Olanipekun, Pankaj Bansal, Sean Kiley, Juan Carlos Leoni, Jose Nativí, Melissa Lyle, Mathew Thomas, Basar Sareyyupoglu, Si Pham, Michael Smith, Pablo Moreno Franco, Parag C Patel, Devang Sanghavi
Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched study. BMC rheumatology 8 (1) (2024)
Zahra Tadayon, Seyed Abolhassan Shahzadeh Fazeli, Nasser Gholijani, Gholamreza Daryabor
Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet's disease among Iranians. BMC rheumatology 8 (1) (2024)
Zahra A Fazal, Ana Michelle Avina-Galindo, Shelby Marozoff, Jessie Kwan, Na Lu, J Antonio Avina-Zubieta
Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies. BMC rheumatology 8 (1) (2024)
Laura C Coates, Proton Rahman, Philip J Mease, May Shawi, Emmanouil Rampakakis, Alexa P Kollmeier, Xie L Xu, Soumya D Chakravarty, Iain B McInnes, Lai-Shan Tam
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study. BMC rheumatology 8 (1) (2024)
Jie Chang, Gang Wang
The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study. BMC rheumatology 8 (1) (2024)
Elizabeth D Ferucci, Peter Holck
An assessment of cardiovascular disease hospitalizations and disparities by race in patients with rheumatic disease hospitalizations in Alaska, 2015-2018. BMC rheumatology 8 (1) (2024)
Lei Zhu, Larry W Moreland, Dana P Ascherman
Cross-sectional association between social and demographic factors and disease activity in rheumatoid arthritis. BMC rheumatology 8 (1) (2024)
Jie Chang, Gang Wang
The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study. BMC rheumatology 8 (1) (2024)
Michael Schultze, Elena Garal-Pantaler, Marc Pignot, Roger A Levy, Heike Carnarius, Matthias Schneider, Kerry Gairy
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany. BMC rheumatology 8 (1) (2024)
Savia de Souza, Ruth Williams, Elena Nikiphorou
Clinician and patient views on janus kinase inhibitors in the treatment of inflammatory arthritis: a mixed methods study. BMC rheumatology 8 (1) (2024)
Alexis Ogdie, Joseph F Merola, Philip J Mease, Christopher T Ritchlin, Jose U Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D Chakravarty, Wayne Langholff, Yanli Wang, Olivia Choi, Yevgeniy Krol, Alice B Gottlieb
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study. BMC rheumatology 8 (1) (2024)
Danfeng Xu, Bing Wu
Association between systemic lupus erythematosus and osteoporosis: a mendelian randomization analysis. BMC rheumatology 8 (1) (2024)
Jeffrey A Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, Gerd R Burmester, Simon Lf Walsh, Michael Kreuter, Christian Stock, Steven Sambevski, Margarida Alves, Paul Emery
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis. BMC rheumatology 8 (1) (2024)
Atiyeh Mellati, Samaneh Soltani, Tohid Kazemi, Nooshin Ahmadzadeh, Maryam Akhtari, Elham Madreseh, Ahmadreza Jamshidi, Elham Farhadi, Mahdi Mahmoudi
Determination of IL-23 receptor expression and gene polymorphism (rs1884444) in Iranian patients with ankylosing spondylitis. BMC rheumatology 8 (1) (2024)
Cécile-Audrey Durel, Eric Simon Thervet, Dominique Chauveau, Aurélie Schmidt, Benjamin Terrier, Pierre M Bataille
Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use. BMC rheumatology 8 (1) (2024)
Atiyeh Mellati, Samaneh Soltani, Tohid Kazemi, Nooshin Ahmadzadeh, Maryam Akhtari, Elham Madreseh, Ahmadreza Jamshidi, Elham Farhadi, Mahdi Mahmoudi
Determination of IL-23 receptor expression and gene polymorphism (rs1884444) in Iranian patients with ankylosing spondylitis. BMC rheumatology 8 (1) (2024)
Alexis Ogdie, Joseph F Merola, Philip J Mease, Christopher T Ritchlin, Jose U Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D Chakravarty, Wayne Langholff, Yanli Wang, Olivia Choi, Yevgeniy Krol, Alice B Gottlieb
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study. BMC rheumatology 8 (1) (2024)
Nasimah Maricar, Gillian Yeowell, Trixy David, Behram Khan, Anne Barton, Kimme L Hyrich, Sandra E Hartley
Barriers and enablers to engagement in exercise and physical activity in non-English speaking South Asian people with chronic musculoskeletal disease. BMC rheumatology 8 (1) (2024)
Zahra Tadayon, Seyed Abolhassan Shahzadeh Fazeli, Nasser Gholijani, Gholamreza Daryabor
Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet's disease among Iranians. BMC rheumatology 8 (1) (2024)
Elizabeth D Ferucci, Peter Holck
An assessment of cardiovascular disease hospitalizations and disparities by race in patients with rheumatic disease hospitalizations in Alaska, 2015-2018. BMC rheumatology 8 (1) (2024)
Zahra Tadayon, Seyed Abolhassan Shahzadeh Fazeli, Nasser Gholijani, Gholamreza Daryabor
Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet's disease among Iranians. BMC rheumatology 8 (1) (2024)
Nadine Schäffer Blum, Bente Appel Esbensen, Mikkel Østergaard, Ann Bremander, Oliver Hendricks, Luise Holberg Lindgren, Lena Andersen, Kim Vilbaek Jensen, Jette Primdahl
Patients' experience of a novel interdisciplinary nurse-led self-management intervention (INSELMA)-a qualitative evaluation. BMC rheumatology 8 (1) (2024)
Nadine Schäffer Blum, Bente Appel Esbensen, Mikkel Østergaard, Ann Bremander, Oliver Hendricks, Luise Holberg Lindgren, Lena Andersen, Kim Vilbaek Jensen, Jette Primdahl
Patients' experience of a novel interdisciplinary nurse-led self-management intervention (INSELMA)-a qualitative evaluation. BMC rheumatology 8 (1) (2024)
Julie Katrine Karstensen, Ann Bremander, Jeanette Reffstrup Christensen, Jette Primdahl
Participation in cardiovascular screening consultations, the who, when and why - A cohort study on patients with rheumatoid arthritis. BMC rheumatology 8 (1) (2024)
Jeffrey A Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, Gerd R Burmester, Simon Lf Walsh, Michael Kreuter, Christian Stock, Steven Sambevski, Margarida Alves, Paul Emery
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis. BMC rheumatology 8 (1) (2024)
Laura C Coates, Proton Rahman, Philip J Mease, May Shawi, Emmanouil Rampakakis, Alexa P Kollmeier, Xie L Xu, Soumya D Chakravarty, Iain B McInnes, Lai-Shan Tam
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study. BMC rheumatology 8 (1) (2024)
Laura C Coates, Proton Rahman, Philip J Mease, May Shawi, Emmanouil Rampakakis, Alexa P Kollmeier, Xie L Xu, Soumya D Chakravarty, Iain B McInnes, Lai-Shan Tam
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study. BMC rheumatology 8 (1) (2024)
Ayouba Tinni Ismael, Kabore Fulgence, Bayala Yannick Laurent Tchenadoyo, Yameogo Wendyam Nadège, Zabsonre/Tiendrebeogo Wendlassida Stéphanie Joelle, Ouedraogo Aboubakar, Zongo Yamyelle Enselme, Traore Awa, Bonkoungou Marcellin, Ouedraogo Dieu-Donné
Epidemiology and diagnosis of gout in sub-saharan Africa: a scoping review. BMC rheumatology 8 (1) (2024)
Ayouba Tinni Ismael, Kabore Fulgence, Bayala Yannick Laurent Tchenadoyo, Yameogo Wendyam Nadège, Zabsonre/Tiendrebeogo Wendlassida Stéphanie Joelle, Ouedraogo Aboubakar, Zongo Yamyelle Enselme, Traore Awa, Bonkoungou Marcellin, Ouedraogo Dieu-Donné
Epidemiology and diagnosis of gout in sub-saharan Africa: a scoping review. BMC rheumatology 8 (1) (2024)
Elizabeth D Ferucci, Peter Holck
An assessment of cardiovascular disease hospitalizations and disparities by race in patients with rheumatic disease hospitalizations in Alaska, 2015-2018. BMC rheumatology 8 (1) (2024)
Jie Chang, Gang Wang
The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study. BMC rheumatology 8 (1) (2024)
Savia de Souza, Ruth Williams, Elena Nikiphorou
Clinician and patient views on janus kinase inhibitors in the treatment of inflammatory arthritis: a mixed methods study. BMC rheumatology 8 (1) (2024)
Savia de Souza, Ruth Williams, Elena Nikiphorou
Clinician and patient views on janus kinase inhibitors in the treatment of inflammatory arthritis: a mixed methods study. BMC rheumatology 8 (1) (2024)